Sun Pharma recalls over 1.10 lakh bottles of generic drug in U.S. market
The Hindu
The U.S. arm of the domestic pharma major is recalling Tadalafil tablets in the American market, according to the latest enforcement report of the USFDA
Drug major Sun Pharmaceutical Industries is recalling over 1.10 lakh bottles of a generic medication used to treat erectile dysfunction in men in the U.S. market due to a manufacturing error.
The U.S. arm of the domestic pharma major is recalling Tadalafil tablets in the American market, according to the latest enforcement report of the U.S. Food and Drug Administration (USFDA).
The Mumbai-based drugmaker is recalling the product in 30-count bottles of 5mg and 20 mg strengths.